Azole-Resistant COVID-19-Associated Pulmonary Aspergillosis in an Immunocompetent Host: A Case Report

被引：85

作者：

Meijer, Eelco F. J. ^{[1
,2
,3
]}

Dofferhoff, Anton S. M. ^{[3
,4
]}

Hoiting, Oscar ^{[5
]}

Buil, Jochem B. ^{[1
,2
]}

Meis, Jacques F. ^{[1
,2
,3
,6
]}

机构：

[1] Radboud Univ Nijmegen, Dept Med Microbiol, Med Ctr, NL-6500 HB Nijmegen, Netherlands

[2] Ctr Expertise Mycol Radboudumc CWZ, NL-6532 SZ Nijmegen, Netherlands

[3] Canisius Wilhelmina Hosp CWZ, Dept Med Microbiol & Infect Dis, NL-6532 SZ Nijmegen, Netherlands

[4] Canisius Wilhelmina Hosp CWZ, Dept Internal Med, NL-6532 SZ Nijmegen, Netherlands

[5] Canisius Wilhelmina Hosp CWZ, Dept Intens Care Med, NL-6532 SZ Nijmegen, Netherlands

[6] Univ Fed Parana, Bioproc Engn & Biotechnol Grad Program, BR-81531970 Curitiba, Parana, Brazil

来源：

JOURNAL OF FUNGI | 2020年 / 6卷 / 02期

关键词：

SARS-CoV-2; co-infection; pulmonary aspergillosis; ICU; azole-resistantAspergillus; Aspergillus fumigatus; CAPA; TR(34)L98H; BRONCHOALVEOLAR LAVAGE FLUID; CRITICALLY-ILL PATIENTS; LATERAL-FLOW DEVICE; BETA-D-GLUCAN; FUNGAL DISEASES; GALACTOMANNAN; DIAGNOSIS; FUMIGATUS;

D O I：

10.3390/jof6020079

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

COVID-19-associated pulmonary aspergillosis (CAPA) is a recently described disease entity affecting patients with severe pulmonary abnormalities treated in intensive care units. Delays in diagnosis contribute to a delayed start of antifungal therapy. In addition, the emergence of resistance to triazole antifungal agents puts emphasis on early surveillance for azole-resistantAspergillusspecies. We present a patient with putative CAPA due toAspergillus fumigatuswith identification of a triazole-resistant isolate during therapy. We underline the challenges faced in the management of these cases, the importance of early diagnosis and need for surveillance given the emergence of triazole resistance.

引用

页码：1 / 8

页数：8

共 50 条

[31] COVID-19-Associated Pulmonary Aspergillosis in the Critical Care Setting
Livermore, Jennifer M.
AACN ADVANCED CRITICAL CARE, 2021, 32 (04) : 398 - 403
[32] Mortality in ICU Patients with COVID-19-Associated Pulmonary Aspergillosis
Beltrame, Anna
Stevens, David A.
Haiduven, Donna
JOURNAL OF FUNGI, 2023, 9 (06)
[33] Covid-19-Associated Pulmonary Aspergillosis: The Other Side of the Coin
Costantini, Claudio
van de Veerdonk, Frank L.
Romani, Luigina
VACCINES, 2020, 8 (04) : 1 - 9
[34] Covid-19-associated pulmonary aspergillosis in mechanically ventilated patients
Zeng, Guangting
Wang, Linlin
ANNALS OF INTENSIVE CARE, 2024, 14 (01)
[35] COVID-19-associated pulmonary aspergillosis: an underdiagnosed or overtreated infection?
Rouze, Anahita
Martin-Loeches, Ignacio
Nseir, Saad
CURRENT OPINION IN CRITICAL CARE, 2022, 28 (05) : 470 - 479
[36] Clinical and Imaging Features of COVID-19-Associated Pulmonary Aspergillosis
Fischer, Tim
El Baz, Yassir
Graf, Nicole
Wildermuth, Simon
Leschka, Sebastian
Kleger, Gian-Reto
Pietsch, Urs
Frischknecht, Manuel
Scanferla, Giulia
Strahm, Carol
Walti, Stephan
Dietrich, Tobias Johannes
Albrich, Werner C.
DIAGNOSTICS, 2022, 12 (05)
[37] COVID-19-Associated Pulmonary Aspergillosis: A Year-Long Retrospective Case Series
Salas, Barbara
Mccullagh, Iain
Cranfield, Katie
Fagan, Christine
Geering, Angela
Robb, Ali
COVID, 2022, 2 (07): : 976 - 982
[38] Influenza and COVID-19-associated aspergillosis
Krome, Susanne
PNEUMOLOGIE, 2024, 78 (04): : 229 - 229
[39] Treatment outcome in patients with chronic pulmonary aspergillosis by azole-resistant aspergillus fumigatus
Takeda, Keita
Suzuki, Junko
Nagai, Hideaki
Kawashima, Masahiro
Ohsima, Nobuharu
Tamura, Atsuhisa
Akagawa, Shinobu
Matsui, Hirotoshi
Ohta, Ken
Watanabe, Akira
Kamei, Katsuhiko
EUROPEAN RESPIRATORY JOURNAL, 2016, 48
[40] COVID-19-associated pulmonary aspergillosis (CAPA): how big a problem is it?
Fekkar, Arnaud
Neofytos, Dionysios
Nguyen, Minh-Hong
Clancy, Cornelius J.
Kontoyiannis, Dimitrios P.
Lamoth, Frederic
CLINICAL MICROBIOLOGY AND INFECTION, 2021, 27 (09) : 1376 - 1378

← 1 2 3 4 5 →